Showing posts with label dexilant. Show all posts
Showing posts with label dexilant. Show all posts

Thursday, January 20, 2011

Paragraph IV certification updated at USFDA

The list of Paragraph IV certification is updated by FDA as of January 17, 2011 and it includes 4 new listing as below..

1) Dexlansoprazole Capsules 60 mg (RLD-Dexilant) (Date-25 Aug 2010)
2) Dutasteride and Tamsulosin Hydrochloride Capsules 0.5 mg/0.4 mg (RLD-Jalyn) (Date-26 Oct 2010)
3) Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral solution 17.5 g/3.13 g/1.6 g per bottle    (RLD-Suprep Bowel Prep Kit) (Date-08 Nov 2010)
4) Voriconazole Oral suspension (RLD-Vfend) (Date- 08 Oct 2010)

In my previous post i have mentioned about the suit by pfizer for Vfend (Voriconazole) against Novartis on filing ANDA with para IV certification for Vfend oral suspension.